Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03746756 · ClinicalTrials.gov registry record · NA
Recovery Management Checkups for Primary Care Experiment
A NA study, sponsored by Chestnut Health Systems.
- Completed
- Registry status
- NA
- Development phase
- 266
- Enrollment target
NCT03746756: Completed NA study, sponsored by Chestnut Health Systems.
NCT03746756 is a NA study that has completed, run by Chestnut Health Systems. The registered enrollment target is 266 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03746756, a NA study, has completed, sponsored by Chestnut Health Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
Study Summary
National data show that only 8% of people with past-year substance use disorders (SUD) received any treatment for these disorders in the past year, resulting in high costs, both in terms of their own health and functioning and costs to society. Pilot work demonstrates that the proposed intervention has the potential to significantly increase SUD treatment engagement among patients with SUD within Federally Qualified Health Centers (FQHCs), and thereby reduce substance use and other related consequences. This project is being done in close collaboration with several FQHC providers to facilitate the potential for subsequent dissemination to other FQHCs and primary care settings.
Primary Outcome
Days from enrollment to first alcohol or other drug (AOD) treatment in the 12 months after enrollment, measured with the Global Appraisal of Individual Needs Quick version 3 (GAIN-Q3)
Interventions
- BEHAVIORAL SBIRT
- BEHAVIORAL SBIRT+RMC-PC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
What the finished NCT03746756 record still lists
NCT03746756 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which SBIRT is the first listed.
NCT03746756 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03746756 about?
NCT03746756 is a clinical study titled "Recovery Management Checkups for Primary Care Experiment". National data show that only 8% of people with past-year substance use disorders (SUD) received any treatment for these disorders in the past year, resulting in high costs, both in terms of their own health and functioning and costs to society. Pilot work demonstrates that the proposed intervention ...
What is the current status of trial NCT03746756?
This trial is currently completed. It is a NA study. The enrollment target is 266 participants. The study started on 2017-10-01. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT03746756?
The interventions under investigation include: SBIRT (BEHAVIORAL), SBIRT+RMC-PC (BEHAVIORAL).
Who is sponsoring clinical trial NCT03746756?
This trial is sponsored by Chestnut Health Systems, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03746756's enrollment target sits among peer trials
266 395th of 2000 higher than 1,606 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05098652 · 266 participants · NA
Coaching Dementia Caregivers to Master Care-Resistant Behavior
- NCT06088277 · 266 participants · NA
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
- NCT06261814 · 266 participants · Phase 2
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
- NCT06312124 · 266 participants · NA
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI